Trial intelligence / Profile preview

Effect of Adding Omega-3 to Treatment Regimen in Elderly Patients With Ulcerative Colitis

TCTR20191215001Phase 3Completed

Sponsor
Iran University of Medical Sciences
Start
Dec 2013
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of omega-3 fatty acid in autoimmune colitis, sponsored by Iran University of Medical Sciences. Started Dec 2013; status: completed.

02

Drugs

omega-3 fatty acid
03

Conditions

autoimmune colitis

Beyond the preview

Go deeper on TCTR20191215001.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20191215001.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call